Term ended Nov 8, 2026 · High confidence
20-year base term ended Nov 8, 2026
Nov 8, 2006
Nov 8, 2026
Jun 7, 2011
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 8, 2006, when application 11/594,431, the earliest non-provisional in its chain, was filed (this one was filed Dec 4, 2009) | Nov 8, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,754,739, US 7,956,052, US 8,299,099, US 8,969,386, US 8,993,600) | resolves to Nov 8, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Nov 8, 2026 | High confidence |
This family
| US 8,759,335 | Term ended May 2025 | May 2025 |
| US 7,977,322 | Term ended May 2025 | May 2025 |
| Application PCT/US2006/043289 | PCT application no patent term | no patent term |
| US 7,741,321 | In force Mar 2028 | Mar 2028 |
| US 7,659,268 | In force May 2027 | May 2027 |
| US 8,993,600 | Term ended Nov 2026 | Nov 2026 |
| US 7,754,739 | In force Jun 2028 | Jun 2028 |
| US 7,956,052 | this patent Nov 2026 | Nov 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 6, 2013 Reel 30558, frame 602 | Hadida Ruah, Sara; Hamilton, Matthew; Miller, Mark; Grootenhuis, Peter; Bear, Brian; McCartney, Jason; Zhou, Jinglan; Van Goor, Fredrick | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Jul 10, 2014 Reel 33292, frame 311 | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Macquarie US Trading LLC | Security Interest |
| Feb 1, 2016 Reel 37676, frame 31 | Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated | Assignee Change of Address |
| Oct 14, 2016 Reel 40357, frame 1 | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated | Release of Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 7,754,739, US 7,956,052, US 8,299,099, US 8,969,386, US 8,993,600, ends no earlier than this term, so it caps nothing.